Paper41209563
Advances in Tumor Antigen Vaccines: A New Frontier in Cancer Immunotherapy.
Feng W and 7 others. Int J Med Sci, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Advances in Tumor Antigen Vaccines: A New Frontier in Cancer Immunotherapy. Papers, record 41209563. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41209563
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cancer Vaccines | Major topic |
| Neoplasms | Major topic |
| Antigens, Neoplasm | Major topic |
| Immunotherapy | Major topic |
| Humans | |
| Immune Checkpoint Inhibitors | |
| Combined Modality Therapy | |
| Precision Medicine | |
| Animals |
Source PubMed
References88
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34676374 | Targeting public neoantigens for cancer immunotherapy. | Nat Cancer | 2021 | https://conductscience.org/library/papers/34676374 | PubMed |
| 2 | 38713894 | Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma. | Blood Adv | 2024 | https://conductscience.org/library/papers/38713894 | PubMed |
| 3 | 36851159 | Improved DNA Vaccine Delivery with Needle-Free Injection Systems. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/36851159 | PubMed |
| 4 | 29326426 | mRNA vaccines - a new era in vaccinology. | Nat Rev Drug Discov | 2018 | https://conductscience.org/library/papers/29326426 | PubMed |
| 5 | 38195752 | Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial. | Nat Med | 2024 | https://conductscience.org/library/papers/38195752 | PubMed |
| 6 | 35359994 | T Cell Metabolism in Infection. | Front Immunol | 2022 | https://conductscience.org/library/papers/35359994 | PubMed |
| 7 | 39270889 | Old concepts, new tricks: How peptide vaccines are reshaping cancer immunotherapy? | Int J Biol Macromol | 2024 | https://conductscience.org/library/papers/39270889 | PubMed |
| 8 | 29889594 | Cytokines in the Treatment of Cancer. | J Interferon Cytokine Res | 2019 | https://conductscience.org/library/papers/29889594 | PubMed |
| 9 | 27793569 | Dendritic Cells and Cancer Immunity. | Trends Immunol | 2016 | https://conductscience.org/library/papers/27793569 | PubMed |
| 10 | 37872225 | CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial. | Nat Med | 2023 | https://conductscience.org/library/papers/37872225 | PubMed |
| 11 | 40938661 | Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival. | Hum Vaccin Immunother | 2025 | https://conductscience.org/library/papers/40938661 | PubMed |
| 12 | 33603370 | Application of Radiosensitizers in Cancer Radiotherapy. | Int J Nanomedicine | 2021 | https://conductscience.org/library/papers/33603370 | PubMed |
| 13 | 39244900 | A recent perspective on designing tumor vaccines for tumor immunology. | Int Immunopharmacol | 2024 | https://conductscience.org/library/papers/39244900 | PubMed |
| 14 | 38086815 | Therapeutic cancer vaccines: advancements, challenges, and prospects. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/38086815 | PubMed |
| 15 | 37254712 | Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/37254712 | PubMed |
| 16 | 36612133 | Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36612133 | PubMed |
| 17 | 37897003 | In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/37897003 | PubMed |
| 18 | 33826117 | A Review of Cancer Immunotherapy Toxicity: Immune Checkpoint Inhibitors. | J Med Toxicol | 2021 | https://conductscience.org/library/papers/33826117 | PubMed |
| 19 | 37029123 | Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37029123 | PubMed |
| 20 | 22437871 | Cancer immunotherapy via dendritic cells. | Nat Rev Cancer | 2012 | https://conductscience.org/library/papers/22437871 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42583501 | Artificial intelligence in peptide cancer vaccine design: from neoantigen discovery to immunogenicity prediction. | Front Genet | 2026 | https://conductscience.org/library/papers/42583501 | PubMed |
| 42220542 | Immune interception in cancer: prioritizing vaccination in high-risk and premalignant settings. | Front Immunol | 2026 | https://conductscience.org/library/papers/42220542 | PubMed |
| 41754822 | Integrative Spatial Transcriptomics and Immunoinformatics for Prognostic Multi-Epitope Vaccine Construct Prediction Against Synovial Sarcoma. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41754822 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41209563
GET https://conductscience.org/api/papers/v1/41209563/references?page=2